Some pharmacy high fliers made news this week, while studies looked at workplace issues including pay and harassment
The Victorian Pharmacy Authority again issued a warning on breaches of drugs and poisons legislation. We spoke to AHPRA about the progress of their investigation into keeping practitioners safe, opened after a pharmacist was attacked by a GP angry she had reported his prescribing behaviour. And a new Human Rights Commission report found that many workers, pharmacy assistants included, were subject to sexual harassment at work… which the Pharmacy Guild advised employers need to address.
A nasal spray form of naloxone was added to the PBS, while Novartis pulled its migraine medication, Aimovig, from the PBS listing process, leading to comments by Migraine Australia that the PBAC was bullying drug companies. We looked at new research into triage and management of minor ailments. And the Guild again called for access to the National Immunisation Program across all Australian jurisdictions.
The Graduate Outcomes Survey was published, revealing that pharmacy grads were the most likely of all to find work, though they’re the lowest paid… in their internship year, at least. The PSA and PPA both expressed concern at the low wages.
And congratulations to Chris Alderman, the new editor-in-chief of The Senior Care Pharmacist, publication of the American Society of Consultant Pharmacists; Elise Apolloni, who received an ACT Mental Health Award this week; Trevor Clarkin, the outgoing GM of Gold Cross, for more than 20 years in the job; and the five finalists in the Guild’s Pharmacy of the Year competition: Capital Chemist Chisholm, ACT; Moama Pharmacy, NSW; LiveLife Pharmacy Bowen, Queensland; Wheatbelt Health Centre Pharmacy, Northam, WA; Wizard Pharmacy, Kalgoorlie, WA. From all of us at AJP, congratulations!